BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36502498)

  • 1. Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility.
    Shargian L; Paul M; Nachshon T; Ayada G; Nesher L; Raanani P; Ben-Zvi H; Henig O; Yahav D
    Eur J Clin Microbiol Infect Dis; 2023 Feb; 42(2):177-182. PubMed ID: 36502498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
    Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
    Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
    Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
    Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
    Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of Viridians Group of Streptococci isolated from infective endocarditis patients from 2018 to 2023.
    Jagadeesan N; Karur K; Nandini MP; Manjunath CN; Prapulla Kumari N; Praveen Kumar HD
    Indian J Med Microbiol; 2024; 49():100576. PubMed ID: 38556250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci.
    Escrihuela-Vidal F; Berbel D; Fernández-Hidalgo N; Escolà-Vergé L; Muñoz P; Olmedo M; Goenaga MÁ; Goikoetxea J; Fariñas MC; De Alarcón A; Miró JM; Ojeda G; Plata A; Cuervo G; Carratalà J;
    Clin Infect Dis; 2023 Nov; 77(9):1273-1281. PubMed ID: 37345869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
    Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
    J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
    Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactam antibiotics and viridans group streptococci.
    Lopardo HA; Vigliarolo L; Bonofiglio L; Gagetti P; García Gabarrot G; Kaufman S; Mollerach M; Toresani I; von Specht M
    Rev Argent Microbiol; 2022; 54(4):335-343. PubMed ID: 36266147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Resistance Trends in Viridans Group Streptococci Bloodstream Infections Among Immunocompromised Children Receiving Levofloxacin Prophylaxis.
    Quintero AM; Cruz Vidal DA; Klamer BG; Ardura MI; Oyeniran SJ
    J Pediatric Infect Dis Soc; 2023 Jul; 12(7):381-391. PubMed ID: 37490409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
    Presterl E; Lassnigg A; Eder M; Reichmann S; Hirschl AM; Graninger W
    Int J Artif Organs; 2007 Sep; 30(9):798-804. PubMed ID: 17918125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Periodontal Therapy With Amoxicillin-Metronidazole on Pharyngeal Carriage of Penicillin- and Erythromycin-Resistant Viridans Streptococci.
    Mombelli A; Cionca N; Almaghlouth A; Cherkaoui A; Schrenzel J; Giannopoulou C
    J Periodontol; 2016 May; 87(5):539-47. PubMed ID: 26654350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
    Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility against penicillin, ampicillin and vancomycin of viridans group Streptococcus in oral microbiota of patients at risk of infective endocarditis.
    Süzük S; Kaşkatepe B; Çetin M
    Infez Med; 2016 Sep; 24(3):190-3. PubMed ID: 27668898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population.
    Rozkiewicz D; Daniluk T; Sciepuk M; Zaremba ML; Cylwik-Rokicka D; Luczaj-Cepowicz E; Milewska R; Marczuk-Kolada G; Stokowska W
    Adv Med Sci; 2006; 51 Suppl 1():191-5. PubMed ID: 17460837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia.
    Ruhayel SD; Foley DA; Hamilton K; Ferguson P; Kotecha RS; Bowen AC; Yeoh DK
    Pediatr Infect Dis J; 2021 Sep; 40(9):832-834. PubMed ID: 34285167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of minimum inhibitory concentration by broth microdilution testing versus standard disc diffusion testing in the detection of penicillin, erythromycin and ciprofloxacin resistance in viridans group streptococci.
    Maeda Y; Goldsmith CE; Coulter WA; Mason C; Dooley JSG; Lowery CJ; Millar BC; Moore JE
    J Med Microbiol; 2011 Dec; 60(Pt 12):1782-1786. PubMed ID: 21852527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
    Pericàs JM; Nathavitharana R; Garcia-de-la-Mària C; Falces C; Ambrosioni J; Almela M; García-González J; Quintana E; Marco F; Moreno A; Bayer AS; Miró JM; Karchmer AW;
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin and penicillin resistance mechanisms among viridans group streptococci isolated from blood cultures of adult patients with underlying diseases.
    Ergin A; Eser ÖK; Hasçelik G
    New Microbiol; 2011 Apr; 34(2):187-93. PubMed ID: 21617831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.